EVH Stock Analysis: Buy, Sell, or Hold?

EVH - Evolent Health, Inc Class A Common Stock

SERVICES-MANAGEMENT SERVICES
$3.21
-0.03 (-0.93%) β–Ό
WAIT
LOW Confidence
Protect Your EVH Gains
Last Updated: January 30, 2026
Earnings: Feb 19, 2026 18d

Get Alerted When EVH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: EVH is down 18.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$7.88
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$4.89
34.4% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.4x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: EVH is currently trading at $3.21, which is considered oversold relative to its 30-day fair value range of $3.60 to $4.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.7) compared to its historical average (13.4). Remarkably, the market is currently pricing in an annual earnings decline of 7.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, EVH is in a strong downtrend. The price is currently testing key support at $3.15. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.18 (+183.4%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $3.60 - $4.17
Company Quality Score 46/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

Protect Your Profits

Holding EVH? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 183.4% below Wall St target ($9.18)
  • WARNING: Recommendation downgraded due to -18.5% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $3.60 - $4.17
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $3.16
Resistance Level $4.06
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 10.74
Wall Street Target $9.18 (+183.4%)
Revenue Growth (YoY) -22.8%
Profit Margin -6.2%
Valuation Discount vs History -7.2% cheaper
PE vs Historical 10.7 vs 13.4 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -7.2% (market-implied from PE analysis)
1-Year Target $3.01 (-7%)
2-Year Target $2.79 (-14%)
3-Year Target $2.59 (-20%)
3-Yr Target (if PE normalizes) (PE: 11β†’13) $3.23 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 387.6%) $22.71 (+601%)
Base: (SPY PE: 10.7, Growth: 387.6%) $10.93 (+238%)
Bear: (PE: 9.1, Growth: 387.6%) $9.29 (+187%)
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.7 to 13.4
Stabilization Target: $4.04 (+24.8%)
PE Expansion Potential: +24.8%
Last updated: January 31, 2026 2:47 AM ET
Data refreshes hourly during market hours. Next update: 3:47 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
32 analysts
$310 54 HOLD
PRVA
Privia Health Group Inc
STRONG BUY
21 analysts
$31 57 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 60 HOLD
PHR
Phreesia Inc
STRONG BUY
15 analysts
$29 48 HOLD
HQY
HealthEquity Inc
STRONG BUY
14 analysts
$119 55 HOLD

Advanced EVH Option Strategies

Professional options setups generated by AI based on today's EVH price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for EVH

EVH Technical Chart EVH Price Prediction EVH Earnings Date EVH Investment Advisor EVH Fair Price Analyzer EVH Options Advisor EVH Options Chain EVH Options Analysis EVH Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals